| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.02B | — | -15.5% |
| Cost of Revenue | $4.55B | — | -11.8% |
| Gross Profit | $467.4M | — | -39.7% |
| R&D Expense | $173.3M | — | +31.1% |
| SG&A Expense | $63.9M | — | -2.2% |
| Operating Income | $182.3M | — | -64.2% |
| Pre-tax Income | $208.6M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.20B | -18.8% | +100.9% |
| Accounts Receivable | $2.53B | +14.6% | -7.6% |
| Inventory | $5.73B | +22.4% | +16.2% |
| Current Assets | $12.66B | +2.9% | +28.5% |
| Total Assets | $14.39B | +2.6% | +32.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$917.5M | — | -324.4% |
| Capital Expenditures | $32.3M | — | -27.2% |
| Investing Cash Flow | -$32.3M | — | +27.2% |
| Financing Cash Flow | -$18.7M | — | -137.4% |
| Free Cash Flow | -$949.8M | — | -360.5% |
| -58.2% |
| Income Tax | $40.2M | — | -46.3% |
| Net Income | $168.3M | — | -60.3% |
| EPS (Basic) | $0.28 | — | -61.1% |
| EPS (Diluted) | $0.26 | — | -61.2% |
| $2.35B |
| +0.1% |
| -18.2% |
| Total Liabilities | $7.86B | +1.9% | +58.1% |
| Stockholders' Equity | $6.52B | +3.5% | +11.0% |